Aims and Scope

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Rapid Publication

The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid and efficient communication of the latest research and reviews, allowing the advancement of clinical therapies.

Personal Service

The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.

Enhanced Digital Features

Advances in Therapy offers a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include other enhanced digital features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. Adis can create digital features for you (including infographics and slide decks), or you can submit your own. All these enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. They can either be submitted at the same time as the manuscript or can be submitted retrospectivley. If features are submitted restrospectivley, there is a fee to cover the additional processing steps required.

For questions relating specifically to enhanced digital features, please contact adisdigitalfeatures@springer.com.

Plain Language Summaries

Articles published in Advances in Therapy can be accompanied by Plain Language Summaries to assist in understanding important medical advances. These summaries can help the content to reach a broader audience thus supporting the effective dissemination of research.

Preprints

We encourage posting of preprints of primary research manuscripts on preprint servers, authors' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other time point during consideration in our journal. Once the preprint is published, it is the author's responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and URL link to the published version of the article on the journal website.

Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

Copyright

Advances in Therapy's open access articles are published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Publication Fees

Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of $7100 / €6250. The journal will consider fee discounts for developing countries and this is decided on a case by case basis. Considering the time and effort required for a detailed peer review, we also reward our regular reviewers with the opportunity to publish without the Rapid Service Fee (pending peer review) for every three reviews completed per calendar year.

Open Access

Advances in Therapy offers an open access option for all articles submitted to the journal. If you choose open access publication you will be required to pay an additional fee of €2990/$3760 upon acceptance of your article.

Contact

For more information about the journal, please contact adisrapidplus@springer.com.

Journal information

Publishing model
Hybrid. Open Access options available

Journal metrics

3.260 (2018)
Impact factor
3.066 (2018)
Five year impact factor
22 days
Submission to first decision
372,416 (2018)
Downloads

Latest articles

About this journal

Print ISSN
0741-238X
Abstracted and indexed in
  1. BIOSIS
  2. Biological Abstracts
  3. CAB Abstracts
  4. Chemical Abstracts Service (CAS)
  5. Current Contents/Clinical Medicine
  6. EBSCO Biomedical Reference Collection
  7. EBSCO CINAHL
  8. EBSCO Discovery Service
  9. EMBASE
  10. EMCare
  11. Gale
  12. Gale Academic OneFile
  13. Google Scholar
  14. INIS Atomindex
  15. Institute of Scientific and Technical Information of China
  16. Japanese Science and Technology Agency (JST)
  17. Journal Citation Reports/Science Edition
  18. Medline
  19. Naver
  20. OCLC WorldCat Discovery Service
  21. ProQuest-ExLibris Primo
  22. ProQuest-ExLibris Summon
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SciSearch)
  27. Semantic Scholar
Copyright information

Rights and permissions

Springer Nature policies

© Springer Healthcare Ltd., part of Springer Nature